Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effexor for Depression in Taiwanese Patients
NCT00546494Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of venlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Primary endpoint: Proportion of patients with remission (HAM-D <= 7) at 8 weeks. Started Feb 2004; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00546494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546494.